Polyhexamethylene Guanidine Phosphate Damages Tight Junctions and the F-Actin Architecture by Activating Calpain-1 via the P2RX7/Ca


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
24 Dec 2019
Historique:
received: 14 11 2019
revised: 20 12 2019
accepted: 22 12 2019
entrez: 28 12 2019
pubmed: 28 12 2019
medline: 2 9 2020
Statut: epublish

Résumé

Polyhexamethylene guanidine phosphate (PHMG-p), a member of the polymeric guanidine family, has strong antimicrobial activity and may increase the risk of inflammation-associated pulmonary fibrosis. However, the effect of PHMG-p on the barrier function of the bronchial epithelium is unknown. Epithelial barrier functioning is maintained by tight junctions (TJs); damage to these TJs is the major cause of epithelial barrier breakdown during lung inflammation. The present study showed that, in BEAS-2B human bronchial epithelial cells, exposure to PHMG-p reduced the number of TJs and the E-cadherin level and impaired the integrity of the F-actin architecture. Furthermore, exposure to PHMG-p stimulated the calcium-dependent protease calpain-1, which breaks down TJs. However, treatment with the calpain-1 inhibitor, ALLN, reversed the PHMG-p-mediated impairment of TJs and the F-actin architecture. Furthermore, exposure to PHMG-p increased the intracellular Ca

Identifiants

pubmed: 31878359
pii: cells9010059
doi: 10.3390/cells9010059
pmc: PMC7016582
pii:
doi:

Substances chimiques

Actins 0
Antigens, CD 0
CDH1 protein, human 0
Cadherins 0
Guanidines 0
P2RX7 protein, human 0
Receptors, Purinergic P2X7 0
polyhexamethyleneguanidine 31961-54-3
Calpain EC 3.4.22.-
Apyrase EC 3.6.1.5
CD39 antigen EC 3.6.1.5
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Korea Ministry of Environment (MOE) as "the Environmental Health Action Program"
ID : 2017001360001

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Molecules. 2018 Aug 07;23(8):
pubmed: 30087305
N Engl J Med. 2000 May 4;342(18):1334-49
pubmed: 10793167
Arch Toxicol. 2016 Mar;90(3):617-32
pubmed: 25716161
Eur Respir J. 2012 Feb;39(2):419-28
pubmed: 21778164
Tissue Barriers. 2013 Apr 1;1(2):e24783
pubmed: 24665393
Annu Rev Cell Dev Biol. 2007;23:237-61
pubmed: 17539752
J Immunol. 2009 Apr 1;182(7):4378-85
pubmed: 19299738
Int J Mol Sci. 2013 May 10;14(5):9906-46
pubmed: 23665898
Biochim Biophys Acta. 2008 Mar;1778(3):660-9
pubmed: 17854762
Biochim Biophys Acta. 1984 Jan 11;769(1):57-66
pubmed: 6691980
Neural Plast. 2016;2016:8928530
pubmed: 27795859
Br J Pharmacol. 2007 Feb;150(4):445-54
pubmed: 17211459
Semin Cell Dev Biol. 2015 Jun;42:47-57
pubmed: 25951797
J Med Microbiol. 2008 Dec;57(Pt 12):1523-8
pubmed: 19018024
Biol Pharm Bull. 2001 Sep;24(9):1093-6
pubmed: 11558578
Nat Rev Mol Cell Biol. 2001 Apr;2(4):285-93
pubmed: 11283726
Science. 2014 Nov 21;346(6212):1000-3
pubmed: 25414314
J Appl Bacteriol. 1984 Aug;57(1):115-24
pubmed: 6386785
J Med Microbiol. 2012 Oct;61(Pt 10):1421-7
pubmed: 22871428
Biochim Biophys Acta. 1983 Nov 23;735(3):380-6
pubmed: 6639946
Pflugers Arch. 2017 Jan;469(1):135-147
pubmed: 27921210
J Biomed Sci. 2013 May 01;20:26
pubmed: 23634990
Am J Physiol. 1987 Dec;253(6 Pt 1):C854-61
pubmed: 3425707
J Biol Chem. 2011 Jan 28;286(4):2750-61
pubmed: 21084306
Front Biosci. 2008 May 01;13:6662-81
pubmed: 18508686
Results Immunol. 2014 Aug 01;4:62-7
pubmed: 25379376
J Toxicol Sci. 2016;41(6):711-717
pubmed: 27853099
J Clin Invest. 1986 Dec;78(6):1513-22
pubmed: 2431002
Purinergic Signal. 2015 Dec;11(4):435-40
pubmed: 26318434
Immunology. 1992 Nov;77(3):330-7
pubmed: 1478679
J Immunol. 2011 Jun 1;186(11):6119-28
pubmed: 21508263
Part Fibre Toxicol. 2012 Aug 29;9:35
pubmed: 22931549
Biochim Biophys Acta. 2008 Mar;1778(3):588-600
pubmed: 17916321
Toxicology. 2019 Feb 15;414:35-44
pubmed: 30629986
EMBO J. 2002 Apr 15;21(8):1948-56
pubmed: 11953314
J Immunol. 2004 Apr 15;172(8):4987-94
pubmed: 15067080
Int J Mol Sci. 2019 May 09;20(9):
pubmed: 31075901
Toxicol Lett. 2018 Apr;286:108-119
pubmed: 29309811
Am J Physiol Lung Cell Mol Physiol. 2017 Mar 1;312(3):L309-L325
pubmed: 27979859
J Endocrinol. 2012 May;213(2):123-41
pubmed: 22396456
Science. 1996 May 3;272(5262):735-8
pubmed: 8614837

Auteurs

Sun Woo Jin (SW)

College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.

Gi Ho Lee (GH)

College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.

Hoa Thi Pham (HT)

College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.

Jae Ho Choi (JH)

College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.

Hye Gwang Jeong (HG)

College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH